In this area, Novartis focuses on diseases of the heart and blood vessels, kidneys, and metabolism, which are among the most common causes of deteriorating health and mortality in modern society. The emphasis is on early risk detection, prevention of complications, and the development of medicines for both chronic and rare diseases.